Park Medi World FY26 net profit rises 27% to ₹2,735.57 million
Park Medi World reported a consolidated net profit of ₹2,735.57 million for FY26, a 27% increase from the previous year, driven by a 20.5% rise in revenue to ₹16,793.56 million. The company expanded its operations through acquisitions worth ₹2,850 million and utilized ₹7,023.02 million of its IPO proceeds for debt repayment and capital expenditure.
*this image is generated using AI for illustrative purposes only.
Park Medi World reported a consolidated net profit of ₹2,735.57 million for the financial year ended March 31, 2026, representing a 27% increase from ₹2,154.41 million in the previous year. Revenue from operations rose 20.5% to ₹16,793.56 million from ₹13,935.70 million in FY25, bolstered by the inclusion of newly acquired subsidiaries and the expansion of healthcare services. The board approved the audited financial results at its meeting held on May 12, 2026.
The company's standalone net profit for FY26 stood at ₹366.16 million, a significant rise from ₹71.80 million in the prior year. Standalone revenue from operations increased to ₹1,289.65 million from ₹915.82 million. The earnings per share (EPS) for the year on a consolidated basis was ₹6.87, compared to ₹5.60 in the previous year.
Financial Performance
The growth in consolidated profitability was supported by a 24.1% increase in total income, which reached ₹17,109.65 million. Total expenses for the year amounted to ₹13,563.81 million, up from ₹11,403.11 million in FY25. The profit before tax for the year was ₹3,545.84 million, compared to ₹2,856.70 million in the previous year.
| Metric (₹ in Millions) | FY26 | FY25 |
|---|---|---|
| Revenue from operations | 16,793.56 | 13,935.70 |
| Total Income | 17,109.65 | 14,259.81 |
| Total Expenses | 13,563.81 | 11,403.11 |
| Net Profit | 2,735.57 | 2,154.41 |
| Earnings Per Share (₹) | 6.87 | 5.60 |
Acquisitions and Expansion
During the year, the company completed several strategic acquisitions to expand its footprint. It acquired 100% shareholding in K P S Wellness Private Limited for ₹1,500 million and SVPD Healthcare Private Limited for ₹950 million. Additionally, it acquired Krishna Super-Speciality Hospital for ₹400 million. These acquisitions added significant bed capacity and specialized healthcare facilities to the company's network. The company also commenced operations of a new 350-bedded multi-super specialty hospital in Panchkula on April 10, 2026.
Capital Allocation and IPO Proceeds
The company successfully completed its initial public offering (IPO) in December 2025, issuing 56,790,123 equity shares at an issue price of ₹162 per share. The total IPO proceeds of ₹7,700 million were utilized for debt repayment, capital expenditure, and inorganic acquisitions. As of March 31, 2026, the company had utilized ₹7,023.02 million of the proceeds, with ₹676.98 million pending for utilization primarily for capital expenditure projects.
Agiwal & Associates, Chartered Accountants, audited the standalone and consolidated annual financial results and issued an unmodified opinion, confirming that the results give a true and fair view of the company's financial position.
Historical Stock Returns for Park Medi World
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -6.08% | -13.11% | +3.96% | +71.78% | +71.78% | +71.78% |
How will the integration of K P S Wellness and SVPD Healthcare impact operating margins in the coming fiscal year?
What is the expected timeline for the new 350-bedded Panchkula hospital to reach full capacity and contribute to revenue?
With the majority of IPO proceeds utilized, what are the company's funding strategies for future capital expenditure or acquisitions?
17
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
